Trial intelligence / Profile preview

Retrospective MRI study of long-term SSRI exposure during adolescent versus adult brain development in OCD

NL-OMON37719Withdrawn

Sponsor
Amsterdam University Medical Center
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of citalopram in obsessive compulsive disorder (OCD) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Serotonin system function by phMRI with citalopram challenge, Microarchitecture of serotonin projections by DTI and 1 more. Planned start Jan 2012; status: withdrawn.

02

Drugs

citalopram
03

Conditions

obsessive compulsive disorder (OCD)

Beyond the preview

Go deeper on NL-OMON37719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON37719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call